Found 6 matching trials
26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension
PHASE3The primary objective of this trial is to assess the efficacy and safety of...
Location
1235.8.61003 Boehringer Ingelheim Investigational Site
Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus
PHASE3To demonstrate that the fixed dose combination of telmisartan and amlodipin...
Location
1235.21.901 Boehringer Ingelheim Investigational Site
Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension
PHASE3The primary objective of this trial is to demonstrate that the fixed dose c...
Location
1235.6.61003 Boehringer Ingelheim Investigational Site
Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension
PHASE3The primary objectives of this trial are (a) to demonstrate that the fixed-...
Location
1235.5.32004 Boehringer Ingelheim Investigational Site
Telmisartan and Amlodipine Versus Monocomponent Tablets
PHASE1This study will be an open-label, randomized, two-treatment, two-period, tw...
Location
1235.41.0001 Boehringer Ingelheim Investigational Site
Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension
PHASE3The primary objective of this trial is to demonstrate that following eight ...
Location
1235.20.525 Boehringer Ingelheim Investigational Site